{"abstract":null,"action":"Notice of public meeting; request for comments.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2014/07/09/2014-15990.html","cfr_references":[],"citation":"79 FR 38909","comment_url":null,"comments_close_on":null,"correction_of":null,"corrections":[],"dates":null,"disposition_notes":null,"docket_ids":["Docket No. FDA-2014-N-0851"],"dockets":[{"supporting_documents":[],"agency_name":null,"documents":[{"comment_count":5,"comment_start_date":"2014-07-09","updated_at":"2023-03-01T13:13:13.578-05:00","comment_url":"https://www.regulations.gov/commenton/FDA-2014-N-0851-0001","allow_late_comments":null,"id":"FDA-2014-N-0851-0001","comment_end_date":"2014-11-29","regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"FDA-2014-N-0851","title":"Public Meeting on Patient-Focused Drug Development for Hemophilia A, Hemophilia B, von Willebrand Disease and other Heritable Bleeding Disorders"}],"document_number":"2014-15990","effective_on":null,"end_page":38910,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2014/07/09/2014-15990.xml","html_url":"https://www.federalregister.gov/documents/2014/07/09/2014-15990/public-meeting-on-patient-focused-drug-development-for-hemophilia-a-hemophilia-b-von-willebrand","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2014-15990?publication_date=2014-07-09","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2014-07-09/2014-15990/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":700,"last_updated":"2026-07-26 00:15:03 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2014-07-09/pdf/2014-15990.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2014-15990.pdf?1404823819","publication_date":"2014-07-09","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2014/07/09/2014-15990.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_count":5,"agency_id":"FDA","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-2014-N-0851","supporting_documents_count":0,"docket_id":"FDA-2014-N-0851","document_id":"FDA-2014-N-0851-0001","regulation_id_number":null,"title":"Public Meeting on Patient-Focused Drug Development for Hemophilia A, Hemophilia B, von Willebrand Disease and other Heritable Bleeding Disorders","checked_regulationsdotgov_at":"2023-03-01T18:13:12Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":38909,"subtype":null,"title":"Public Meeting on Patient-Focused Drug Development for Hemophilia A, Hemophilia B, von Willebrand Disease, and Other Heritable Bleeding Disorders","toc_doc":"Patient-Focused Drug Development for Hemophilia A, Hemophilia B, von Willebrand Disease, and Other Heritable Bleeding Disorders","toc_subject":"Meetings:","topics":[],"type":"Notice","volume":79}